Join WhatsApp Community

Severe Heart Failure Case Study: LVEF Increased from 15% to 55% Over 7 Months

Case Overview

Mr. Vasudevan Nair, a 74-year-old retired resident of Pune, visited Madhavbaug Ambegaon Budruk with severe breathlessness, weakness, constipation, bloating and dependence on wheelchair support. He had Ischemic Heart Disease (IHD) and Congestive Heart Failure (CHF), with a severely reduced Left Ventricular Ejection Fraction (LVEF) of 15%. His symptoms significantly limited mobility and everyday activity. A personalised, physician-supervised care plan combining regular medical review, lifestyle guidance, dietary support, structured wellness therapies and gradual activity progression was initiated. Over approximately seven months, documented improvements were observed in cardiac function, metabolic parameters, exercise capacity and functional independence.

15% → 55%

LVEF

7.1% → 5.3%

HbA1c

12.90 → 14.78

VO₂ Max

227.44 → 124 mg/dL

Total Cholesterol

Patient at a Glance

Patient Mr. Vasudevan Nair
Age and location 74 years, Pune
Primary diagnosis Ischemic Heart Disease (IHD) and Congestive Heart Failure (CHF)
Main concerns Severe breathlessness, weakness, reduced exercise tolerance, constipation, bloating and wheelchair dependency
Care setting Madhavbaug Ambegaon Budruk
Duration Approximately 7 months
Key documented result LVEF increased from 15% at presentation to 55% at the latest follow-up
Current status Improved mobility, reduced breathlessness, better exercise tolerance and ongoing follow-up

The Patient Story

Before beginning treatment at Madhavbaug, Mr. Nair experienced progressive physical limitations related to his cardiac condition. Breathlessness while walking, severe weakness, constipation, bloating and poor exercise tolerance disrupted his daily routine. His mobility gradually declined to the point that he required wheelchair support. Routine activities became difficult, reducing his independence and confidence. Concerned about his worsening symptoms and quality of life, he visited Madhavbaug Ambegaon Budruk for a structured and supervised cardiovascular care programme.

Symptoms and Impact on Daily Life

Symptom or limitation Severity or frequency Effect on daily life
Breathlessness on exertion Severe and present for several months Difficulty walking even short distances
Severe weakness Frequent and limiting Reduced participation in routine activities
Wheelchair dependency Required at presentation Needed assistance for mobility
Constipation and bloating Persistent at presentation Reduced comfort and affected general well-being

Medical History Before Madhavbaug

The patient had a confirmed diagnosis of Ischemic Heart Disease and Congestive Heart Failure and had undergone cardiac evaluation and conventional medical management. Despite prior treatment, severe breathlessness, weakness and functional limitations continued. Investigations showed severe left ventricular dysfunction and substantially reduced cardiac pumping efficiency. Elevated HbA1c and an unfavourable lipid profile added to his overall cardiovascular risk. Ongoing medication was reviewed and coordinated according to the treating physician’s advice.

Why He Chose Madhavbaug

Mr. Nair sought a physician-supervised programme focused on improving cardiovascular health, exercise tolerance, mobility and quality of life. At Madhavbaug Ambegaon Budruk, he received a personalised assessment, regular follow-up and an integrated care plan based on his age, clinical condition and functional capacity.

Clinical Assessment and Treatment Goals

Mr. Nair presented with advanced Ischemic Heart Disease and Congestive Heart Failure associated with severe left ventricular dysfunction. The major clinical concerns were severe breathlessness, reduced exercise tolerance, mobility limitations, elevated HbA1c and dyslipidaemia. The treatment priorities were to support cardiovascular function, improve functional capacity, optimise metabolic parameters, enhance mobility and improve day-to-day quality of life. Regular monitoring was incorporated throughout the programme to assess symptoms, treatment adherence, cardiac function and exercise capacity.

Personalised Care Plan

Care component What the plan included Frequency or duration Purpose
Clinical assessment and follow-up Regular physician evaluations and review of symptoms and investigations Throughout the programme Monitor progress and modify the plan when required
Structured wellness therapies Individualised Panchakarma and supportive therapies prescribed by the treating doctor As advised Support overall wellness as part of the supervised programme
Dietary guidance Heart-friendly dietary plan Daily Support cardiovascular and metabolic health
Activity and rehabilitation Gradual walking and mobility progression based on tolerance Daily, as advised Improve strength, mobility and exercise tolerance
Medicine coordination Review and coordination of ongoing medicines according to the treating physician’s advice Throughout the programme Support continuity of care and adherence

The care plan was tailored to the patient’s age, cardiovascular status, symptom burden and limited exercise capacity. Physician supervision, lifestyle guidance, dietary recommendations, structured wellness therapies and gradual activity progression were integrated into one programme. Follow-up investigations, symptom monitoring and functional assessments were used to track progress. The approach emphasised safe, gradual improvement, consistent adherence and continued evaluation rather than a one-size-fits-all treatment pathway.

Progress Over Time

Time point Symptoms and function Objective findings Clinical approach
Start of care Wheelchair dependent, severe breathlessness on exertion, severe weakness, constipation and bloating LVEF 15%, HbA1c 7.1%, VO₂ Max 12.90 Comprehensive assessment and personalised care plan initiated
Month 1 Reduced bloating, improved digestion and slightly better energy Clinical improvement noted Treatment sessions, dietary guidance and monitoring continued
Month 2 Reduced breathlessness during routine activity and improved comfort Functional improvement observed Current protocol continued with symptom reassessment
Month 3 Improved walking tolerance and reduced dependence on support Better functional capacity Gradual increase in physical activity encouraged
Latest follow-up Improved mobility, reduced breathlessness and better quality of life LVEF 55%, HbA1c 5.3%, VO₂ Max 14.78, BP 123/74 mmHg Maintenance plan and periodic cardiac monitoring continued

Before-and-After Results

Parameter At presentation Latest follow-up Clinical interpretation
Left Ventricular Ejection Fraction (LVEF) 15% 55% Documented improvement in cardiac pumping function
HbA1c 7.1% 5.3% Improved long-term blood glucose control
VO₂ Max 12.90 14.78 Improved exercise capacity and cardiovascular fitness
Total Cholesterol 227.44 mg/dL 124 mg/dL Improved lipid profile
Blood Pressure Monitored during care 123/74 mmHg Within an acceptable range at the latest follow-up

What the Results Meant for the Patient

One of the most notable documented findings was the increase in LVEF from 15% to 55%. Improvements were also recorded in HbA1c, VO₂ Max and total cholesterol. Alongside these objective changes, Mr. Nair reported less breathlessness, better mobility, greater stamina and increased confidence while completing daily activities. His body weight remained stable at approximately 51 kg. Continued follow-up and monitoring remain important because this is an individual case and the same outcome cannot be assumed for every patient.

Changes in Everyday Life

Mr. Nair reported meaningful improvements in mobility and independence. Activities that had previously required assistance became easier to perform. Breathlessness while walking reduced, stamina improved and he became more comfortable participating in routine daily activities. He also reported feeling more active, confident and independent.

Patient Testimonial

“When I first came to Madhavbaug, I needed wheelchair support and felt breathless even while walking short distances. Simple daily activities left me tired and dependent on others. With regular treatment, follow-ups and guidance from the doctors, my breathlessness reduced, my stamina improved and I gradually became more comfortable performing daily activities. Today, I feel much more active, confident and independent. The improvement in my mobility and overall well-being has made a meaningful difference in my day-to-day life.”

— Mr. Vasudevan Nair

Doctor’s Clinical Note

The documented records indicate improvements in cardiac function, exercise capacity, metabolic parameters and overall functional status during the treatment period. This case highlights the importance of individualised care, regular monitoring, treatment adherence and lifestyle modification. Individual outcomes may vary according to the patient’s medical condition, clinical risk, adherence and other factors. Continued follow-up remains essential.

Reviewing doctor Dr. Dhanashree Mahajan, BAMS, Preventive Cardiologist and Diabetologist
Centre Madhavbaug Ambegaon Budruk
Review date 23 June 2026

Conclusion

Mr. Vasudevan Nair presented with severe breathlessness, wheelchair dependency and advanced cardiac dysfunction associated with Ischemic Heart Disease and Congestive Heart Failure. During approximately seven months of structured, personalised and physician-supervised care, measurable improvements were documented in LVEF, HbA1c, exercise capacity, total cholesterol and daily functioning. His progress demonstrates the value of timely assessment, ongoing monitoring and care tailored to the individual. Patients experiencing breathlessness, severe fatigue, reduced mobility or other possible heart-failure symptoms should seek prompt medical evaluation for personalised guidance.

Understand What the Right Care Plan Could Look Like for You

Every patient’s condition and response are different. Book an assessment with a Madhavbaug doctor to discuss your reports, symptoms and suitable next steps.

BOOK AN APPOINTMENT

Frequently Asked Questions

  1. What is Congestive Heart Failure?
    Congestive Heart Failure is a condition in which the heart cannot pump blood as effectively as the body needs. This may lead to symptoms such as breathlessness, fatigue, swelling, weakness and reduced ability to exercise. The severity and treatment approach differ from one patient to another.
  2. What does LVEF indicate?
    Left Ventricular Ejection Fraction, or LVEF, estimates the percentage of blood pumped out of the heart’s main pumping chamber with each contraction. Doctors use it alongside symptoms, examination findings and other tests to assess cardiac function and guide treatment.
  3. What symptoms may occur with a low ejection fraction?
    A low ejection fraction may be associated with breathlessness, fatigue, weakness, reduced exercise tolerance, swelling, difficulty performing routine activities and, in severe cases, mobility limitations. These symptoms require medical assessment because they may also occur in other conditions.
  4. Why is VO₂ Max important?
    VO₂ Max reflects the body’s ability to use oxygen during physical activity and provides information about exercise capacity and cardiovascular fitness. In a supervised setting, changes in this measure can help doctors understand how a patient’s functional capacity is progressing.
  5. Why are regular follow-ups important?
    Heart failure and related cardiovascular conditions require ongoing monitoring. Follow-up visits allow the doctor to review symptoms, blood pressure, investigations, medication adherence, exercise tolerance and lifestyle measures, and to adjust the care plan when needed.
  6. Will every patient experience the same result?
    No. This page describes one patient’s documented experience. Results vary according to diagnosis, severity, age, other medical conditions, treatment adherence and many individual factors. A doctor must assess each patient and recommend a suitable care plan.

Medical Disclaimer

This case study describes the documented experience of one patient and is provided for educational purposes. It does not guarantee or predict the outcome of another patient. Treatment decisions should be made only after assessment by a qualified healthcare professional. Do not stop, start or change prescribed medicines without medical supervision.

Disclaimer & Patient Consent: This case study is published with full, informed patient consent. Individual results vary depending on medical condition, adherence, and supervision. This article is informational and does not replace medical advice. Please consult a qualified Madhavbaug Ayurvedic doctor before starting any treatment.